MesalazineCardiomyopathy and cardiogenic shock leading to cerebrovascular event: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1548卷 / 1期

关键词：

D O I：

10.1007/s40278-015-9990-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：167 / 167

相关论文

共 50 条

[1] HydroxychloroquineCardiomyopathy leading to cardiogenic shock: case report
[J]. Reactions Weekly, 2017, 1646 (1) : 171 - 171
[2] DobutamineStress cardiomyopathy leading to cardiogenic shock: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 259 - 259
[3] VenlafaxineTakotsubo syndrome leading to cardiogenic shock: case report
[J]. Reactions Weekly, 2021, 1863 (1) : 318 - 318
[4] PropofolAcute myocarditis leading to cardiogenic shock: case report
[J]. Reactions Weekly, 2022, 1913 (1) : 385 - 385
[5] MesalazineFulminant eosinophilic myocarditis leading to cardiogenic shock: case report
[J]. Reactions Weekly, 2021, 1844 (1) : 275 - 275
[6] MethotrexateAcute graft closures leading to cardiogenic shock: case report
[J]. Reactions Weekly, 2016, 1608 (1) : 182 - 182
[7] FluorouracilAcute cardiogenic shock leading to multiple organ dysfunction: case report
[J]. Reactions Weekly, 2014, 1532 (1) : 101 - 101
[8] Multiple drugsLack of efficacy and cardiomyopathy leading to cardiogenic shock: case report
[J]. Reactions Weekly, 2021, 1836 (1) : 530 - 530
[9] EpoprostenolRebound pulmonary arterial hypertension leading to cardiogenic shock : case report
[J]. Reactions Weekly, 2022, 1901 (1) : 244 - 244
[10] Cardiogenic shock -: case report
Link, A
Böhm, M
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (45) : 2417 - 2417

← 1 2 3 4 5 →